In clinical studies, imiquimod 3.75% was shown to detect and treat actinic keratosis (AK) lesions across an entire sun-exposed field such as the full face or balding scalp. The aim of this study was to evaluate imiquimod 3.75% in a real-life clinical setting.
Tambone, S., Fargnoli, M., Capizzi, R., Peris, K., Clinical experience of imiquimod 3.75% for actinic keratosis: results from a case series, <<GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA>>, 2015; (Ottobre): N/A-N/A [http://hdl.handle.net/10807/72789]
Autori: | |
Titolo: | Clinical experience of imiquimod 3.75% for actinic keratosis: results from a case series |
Data di pubblicazione: | 2015 |
Abstract: | In clinical studies, imiquimod 3.75% was shown to detect and treat actinic keratosis (AK) lesions across an entire sun-exposed field such as the full face or balding scalp. The aim of this study was to evaluate imiquimod 3.75% in a real-life clinical setting. |
Lingua: | Inglese |
Rivista: | |
Citazione: | Tambone, S., Fargnoli, M., Capizzi, R., Peris, K., Clinical experience of imiquimod 3.75% for actinic keratosis: results from a case series, <<GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA>>, 2015; (Ottobre): N/A-N/A [http://hdl.handle.net/10807/72789] |
Appare nelle tipologie: | Articolo in rivista, Nota a sentenza |
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.